ELAC2

ElaC homolog 2 (E. coli)
Identifiers
Symbols	ELAC2 ; HPC2; ELC2; FLJ10530; FLJ36693; FLJ42848
External IDs	Template:OMIM5 Template:MGI HomoloGene: 6403
Gene ontology Molecular function Template:GNF GO Template:GNF GO Template:GNF GO Template:GNF GO Cellular component Template:GNF GO Biological process Template:GNF GO
RNA expression pattern
More reference expression data
Orthologs
Template:GNF Ortholog box
Species	Human	Mouse
Entrez	n/a	n/a
Ensembl	n/a	n/a
UniProt	n/a	n/a
RefSeq (mRNA)	n/a	n/a
RefSeq (protein)	n/a	n/a
Location (UCSC)	n/a	n/a
PubMed search	n/a	n/a

ElaC homolog 2 (E. coli), also known as ELAC2, is a human gene.

Further reading

• Bonaldo MF, Lennon G, Soares MB (1997). "Normalization and subtraction: two approaches to facilitate gene discovery". Genome Res. 6 (9): 791–806. PMID 8889548.CS1 maint: Multiple names: authors list (link)
• Satijn DP, Gunster MJ, van der Vlag J; et al. (1997). "RING1 is associated with the polycomb group protein complex and acts as a transcriptional repressor". Mol. Cell. Biol. 17 (7): 4105–13. PMID 9199346.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Sewalt RG, Gunster MJ, van der Vlag J; et al. (1999). "C-Terminal binding protein is a transcriptional repressor that interacts with a specific class of vertebrate Polycomb proteins". Mol. Cell. Biol. 19 (1): 777–87. PMID 9858600.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Rebbeck TR, Walker AH, Zeigler-Johnson C; et al. (2000). "Association of HPC2/ELAC2 genotypes and prostate cancer". Am. J. Hum. Genet. 67 (4): 1014–9. PMID 10986046.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Tavtigian SV, Simard J, Teng DH; et al. (2001). "A candidate prostate cancer susceptibility gene at chromosome 17p". Nat. Genet. 27 (2): 172–80. doi:10.1038/84808. PMID 11175785.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Xu J, Zheng SL, Carpten JD; et al. (2001). "Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer". Am. J. Hum. Genet. 68 (4): 901–11. PMID 11254448.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Rökman A, Ikonen T, Mononen N; et al. (2001). "ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer". Cancer Res. 61 (16): 6038–41. PMID 11507049.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Wang L, McDonnell SK, Elkins DA; et al. (2001). "Role of HPC2/ELAC2 in hereditary prostate cancer". Cancer Res. 61 (17): 6494–9. PMID 11522646.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Shea PR, Ferrell RE, Patrick AL; et al. (2002). "ELAC2 and prostate cancer risk in Afro-Caribbeans of Tobago". Hum. Genet. 111 (4–5): 398–400. doi:10.1007/s00439-002-0816-1. PMID 12384782.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Camp NJ, Tavtigian SV (2003). "Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer". Am. J. Hum. Genet. 71 (6): 1475–8. PMID 12515253.
• Fujiwara H, Emi M, Nagai H; et al. (2003). "Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series". J. Hum. Genet. 47 (12): 641–8. doi:10.1007/s100380200099. PMID 12522685.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Korver W, Guevara C, Chen Y; et al. (2003). "The product of the candidate prostate cancer susceptibility gene ELAC2 interacts with the gamma-tubulin complex". Int. J. Cancer. 104 (3): 283–8. doi:10.1002/ijc.10945. PMID 12569551.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Shi Y, Sawada J, Sui G; et al. (2003). "Coordinated histone modifications mediated by a CtBP co-repressor complex". Nature. 422 (6933): 735–8. doi:10.1038/nature01550. PMID 12700765.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Takaku H, Minagawa A, Takagi M, Nashimoto M (2003). "A candidate prostate cancer susceptibility gene encodes tRNA 3' processing endoribonuclease". Nucleic Acids Res. 31 (9): 2272–8. PMID 12711671.CS1 maint: Multiple names: authors list (link)
• Severi G, Giles GG, Southey MC; et al. (2003). "ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer". J. Natl. Cancer Inst. 95 (11): 818–24. PMID 12783937.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Takahashi H, Lu W, Watanabe M; et al. (2003). "Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men". Int. J. Cancer. 107 (2): 224–8. doi:10.1002/ijc.11347. PMID 12949798.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Stanford JL, Sabacan LP, Noonan EA; et al. (2003). "Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study". Cancer Epidemiol. Biomarkers Prev. 12 (9): 876–81. PMID 14504198.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Adler D, Kanji N, Trpkov K; et al. (2004). "HPC2/ELAC2 gene variants associated with incident prostate cancer". J. Hum. Genet. 48 (12): 634–8. doi:10.1007/s10038-003-0091-6. PMID 14625808.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Ota T, Suzuki Y, Nishikawa T; et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)